Community Hospitals
e-Newsletter
Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

SLIDESHOW: ECRI C-Suite HIT Watch List

</>

6. PET/MR: With the PET/CR becoming a mainstay in the field of oncology, another hybrid machine is looking to make a similar impact: PET/MR. Since the FDA approved the first two PET/MR scanners in 2011, the benefits of this hybrid and its improvement over the PET/CR have emerged. Those advancements include greater detail of internal structures and the possibility of helping physicians detect tumors and cancers. (Photo credit: Courtesy of Siemens Healthcare)